---
title: "COPD home monitoring: uncertain clinical benefit — Vironix"
description: "COPD monitoring did not consistently improve quality of life or utilization; low-certainty evidence leaves important uncertainty."
image: "https://www.vironix.ai/_astro/open_graph_vironix.uvCNQF08_27tYOt.webp"
canonical: "https://www.vironix.ai/research/studies/copd-home-monitoring-review"
source: "https://www.vironix.ai/research/studies/copd-home-monitoring-review"
---

<!-- Generated from https://www.vironix.ai/research/studies/copd-home-monitoring-review. Do not edit this file directly. -->

[Home](https://www.vironix.ai/index.md) [Research & Evidence](https://www.vironix.ai/research.md) COPD home monitoring: uncertain clinical benefit

Study summary · 2022 · Evidence review

# COPD home monitoring: uncertain clinical benefit

COPD monitoring did not consistently improve quality of life or utilization; low-certainty evidence leaves important uncertainty.

Summary by Vironix Health · Source review: November 11, 2026  
[How we select and interpret evidence](https://www.vironix.ai/research/methodology.md)

## Original publication

[Effectiveness of remote home monitoring for patients with Chronic Obstructive Pulmonary Disease (COPD): systematic review](https://link.springer.com/article/10.1186/s12913-022-07938-y)

Fernanda Inagaki Nagase; Tania Stafinski; Melita Avdagovska; Michael K. Stickland; Evelyn Melita Etruw; Devidas Menon

University of Alberta; Alberta Health Services; Covenant Health, Canada

BMC Health Services Research · Online: May 14, 2022 · Issue: 2022

[DOI: 10.1186/s12913-022-07938-y](https://doi.org/10.1186/s12913-022-07938-y)[PubMed](https://pubmed.ncbi.nlm.nih.gov/35568904/)[Open-access source](https://link.springer.com/article/10.1186/s12913-022-07938-y)

Journal version of record. · Full text consulted.

## What was studied

Design

Evidence review

Population

People with COPD

Sample

19 studies: 17 randomized trials and 2 comparative observational studies; 3,144 participants

Intervention

Home transmission of symptoms and measurements, with differing feedback pathways

Comparator

Usual care or monitoring without provider feedback

Follow-up

Monitoring periods of 1–12 months

Study/data period

Included studies conducted in 2006–2018

Review search cutoff

2020-03-13

Setting

Multiple countries

## Methods

Narrative review with limited pooling, risk-of-bias assessment and GRADE. Designs and monitoring technologies differed.

## Findings

Quality of life showed no clear between-group improvement. Seven of nine dedicated-device studies reported similar COPD hospitalization results; two favored monitoring. One study assessed adverse events and eight assessed mortality, without clear group differences.

## Limitations

Evidence certainty was low or very low. Short follow-up, heterogeneous interventions and incomplete reporting limit inference. Sparse safety data do not establish safety equivalence.

## What this means for care delivery

Do not transfer heart-failure or hypertension benefits to COPD. Provider feedback is promising, but its independent effect is not established across programs.

## Explore the evidence

[RPM](https://www.vironix.ai/research.md#careModels=rpm)[Patient reported](https://www.vironix.ai/research.md#careModels=patient-reported)[COPD](https://www.vironix.ai/research.md#conditions=copd)

## Guides citing this study

-   [How do RPM and CCM work together in a managed care team?](https://www.vironix.ai/research/guides/care-team-workflows.md)

```json
{
  "@context": "https://schema.org",
  "@type": "Organization",
  "@id": "https://www.vironix.ai/#organization",
  "name": "Vironix Health",
  "alternateName": "Vironix",
  "url": "https://www.vironix.ai",
  "logo": "https://www.vironix.ai/_astro/Vironix_Logo_Primary_300.CFX8xheF.png",
  "description": "Vironix is a digital health platform that enables healthcare providers to provide AI-enabled virtual care services to their patients, including remote patient monitoring, chronic care management, remote therapeutic monitoring, and more.",
  "sameAs": [
    "https://www.linkedin.com/company/vironix-health"
  ]
}
{
  "@context": "https://schema.org",
  "@type": "WebSite",
  "@id": "https://www.vironix.ai/#website",
  "url": "https://www.vironix.ai",
  "name": "Vironix Health",
  "publisher": {
    "@id": "https://www.vironix.ai/#organization"
  },
  "inLanguage": "en-US"
}
{
  "@context": "https://schema.org",
  "@type": "BreadcrumbList",
  "itemListElement": [
    {
      "@type": "ListItem",
      "position": 1,
      "name": "Home",
      "item": "https://www.vironix.ai/"
    },
    {
      "@type": "ListItem",
      "position": 2,
      "name": "Research & Evidence",
      "item": "https://www.vironix.ai/research"
    },
    {
      "@type": "ListItem",
      "position": 3,
      "name": "COPD home monitoring: uncertain clinical benefit",
      "item": "https://www.vironix.ai/research/studies/copd-home-monitoring-review.html"
    }
  ]
}
{
  "@context": "https://schema.org",
  "@type": "Article",
  "@id": "https://www.vironix.ai/research/studies/copd-home-monitoring-review#article",
  "headline": "COPD home monitoring: uncertain clinical benefit",
  "description": "COPD monitoring did not consistently improve quality of life or utilization; low-certainty evidence leaves important uncertainty.",
  "url": "https://www.vironix.ai/research/studies/copd-home-monitoring-review",
  "mainEntityOfPage": "https://www.vironix.ai/research/studies/copd-home-monitoring-review",
  "inLanguage": "en-US",
  "articleSection": "Research & Evidence",
  "isPartOf": {
    "@id": "https://www.vironix.ai/research"
  },
  "datePublished": "2026-11-16T16:44:13.213Z",
  "dateModified": "2026-11-16T16:44:13.220Z",
  "author": {
    "@type": "Organization",
    "name": "Vironix Health",
    "@id": "https://www.vironix.ai/#organization",
    "url": "https://www.vironix.ai/about"
  },
  "publisher": {
    "@id": "https://www.vironix.ai/#organization"
  },
  "citation": {
    "@type": "ScholarlyArticle",
    "@id": "https://doi.org/10.1186/s12913-022-07938-y",
    "name": "Effectiveness of remote home monitoring for patients with Chronic Obstructive Pulmonary Disease (COPD): systematic review",
    "author": [
      {
        "@type": "Person",
        "name": "Fernanda Inagaki Nagase"
      },
      {
        "@type": "Person",
        "name": "Tania Stafinski"
      },
      {
        "@type": "Person",
        "name": "Melita Avdagovska"
      },
      {
        "@type": "Person",
        "name": "Michael K. Stickland"
      },
      {
        "@type": "Person",
        "name": "Evelyn Melita Etruw"
      },
      {
        "@type": "Person",
        "name": "Devidas Menon"
      }
    ],
    "datePublished": "2022-05-14",
    "url": "https://link.springer.com/article/10.1186/s12913-022-07938-y",
    "identifier": "10.1186/s12913-022-07938-y",
    "isPartOf": {
      "@type": "Periodical",
      "name": "BMC Health Services Research"
    }
  }
}
```
